In the present study, 14/19 patients showed elevated levels of cTnI and 17/21 patients showed elevated levels of NT-proBNP, may be suggesting the importance of these two biomarkers in predicting MI in patients with SSc. Here, TNNI3 is linked to systemic sclerosis.